You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage IV grade 2 follicular lymphoma

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Disseminated Intravascular Coagulation Trial (Antithrombin alfa (INN name), Control (Standard treatment))

Terminated
Has Results
  • Disseminated Intravascular Coagulation
  • Antithrombin alfa (INN name)
  • Control (Standard treatment)
  • (no location specified)
Aug 5, 2021

Lymphoma Diagnosed at Nimes University Hospital From 1999 to

Recruiting
  • Lymphoma, Malignant
    • Nîmes, France
      CHU Nimes
    May 12, 2022

    Ileus Postoperative Trial (ORE001, Placebo)

    Not yet recruiting
    • Ileus Postoperative
    • (no location specified)
    Jul 3, 2023

    Chromogranin A as Blood Marker in Cancer Patients

    Completed
    • Gastric Neoplasms
    • +3 more
    • BRAHMS CgA II KRYPTOR
    • Palo Alto, California
    • +3 more
    Dec 19, 2022

    Pulmonary Sarcoidosis Trial (XTMAB-16 or Placebo)

    Not yet recruiting
    • Pulmonary Sarcoidosis
    • XTMAB-16 or Placebo
    • (no location specified)
    May 25, 2023

    Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Chicago, Saint Louis, Houston (drug, procedure, radiation)

    Completed
    • Leukemia
    • +3 more
    • Chicago, Illinois
    • +2 more
    Oct 24, 2018

    Infection, Hand Injury Wrist, Hand Injuries Trial in Phoenix (Systemic IV Vancomycin, Bier Block, Vancomycin)

    Enrolling by invitation
    • Infection
    • +4 more
    • Systemic IV Vancomycin
    • +2 more
    • Phoenix, Arizona
      Mayo Clinic in Arizona
    Sep 7, 2021

    Profiling to Help Define Need for Neo-Adjuvant Chemotherapy in

    Recruiting
    • Breast Cancer
    • GEP
    • Jette, Brussel, Belgium
      Universitair Ziekenhuis Brussel
    Dec 16, 2022

    Acute Decompensated Heart Failure Trial in Grodzisk Mazowiecki (Empagliflozin 10 MG, Dapagliflozin 10 MG, Placebo)

    Recruiting
    • Acute Decompensated Heart Failure
    • Empagliflozin 10 MG
    • +2 more
    • Grodzisk Mazowiecki, Poland
      Autonomous Public Specialist Western John Paul II Hospital
    Mar 7, 2023

    Hypercortisolism, Diabetes, Type 2 Trial (Mifepristone 300 MG [Korlym], Placebo for mifepristone)

    Not yet recruiting
    • Hypercortisolism
    • Diabetes Mellitus, Type 2
    • Mifepristone 300 MG [Korlym]
    • Placebo for mifepristone
    • (no location specified)
    Mar 6, 2023

    Status Epilepticus, Convulsive Status EPILEPTICUS, Non-Convulsive Status Epilepticus Trial in United States (Ganaxolone,

    Recruiting
    • Status Epilepticus
    • +3 more
    • Birmingham, Alabama
    • +61 more
    Jun 7, 2021

    Atherosclerosis Trial in Monaco (18F-Na PET Scan)

    Not yet recruiting
    • Atherosclerosis
    • 18F-Na PET Scan
    • Monaco, Monaco
      Centre Hospitalier Princesse Grace
    Aug 22, 2023

    Heart Transplanted Patients for Heart Failure (RE-START)

    Not yet recruiting
    • Heart Failure
    • Heart Transplant
    • Xi'an, Shaanxi, China
      First Affiliated Hospital of Xian Jiantong University
    Mar 16, 2023

    Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Venetoclax)

    Not yet recruiting
    • Multiple Myeloma in Relapse
    • Multiple Myeloma, Refractory
    • (no location specified)
    Oct 30, 2023

    Infertility, Poor Ovarian Response Trial in Worldwide (Testosterone gel, Placebo gel)

    Recruiting
    • Infertility
    • Poor Ovarian Response
    • Testosterone gel
    • Placebo gel
    • Antwerp, Belgium
    • +10 more
    Oct 4, 2021

    Endometriosis, Unexplained Infertility Trial in Winston-Salem (Elagolix, Oral Contraceptive)

    Recruiting
    • Endometriosis
    • Unexplained Infertility
    • Winston-Salem, North Carolina
      Wake Forest Univesity Health Sciences
    Dec 1, 2022

    Left Ventricular Remodeling in Type 2 Diabetic Acute Myocardial

    Recruiting
    • Myocardial Infarction
    • Diabetes Mellitus, Type 2
    • SGLT2 inhibitor
    • Seoul, Korea, Republic of
      Seoul St. Mary's Hospital
    Mar 5, 2023

    Hepatocellular Carcinoma Trial in Germany, Spain (Atezolizumab, Bevacizumab, TACE)

    Recruiting
    • Hepatocellular Carcinoma
    • Aachen, Germany
    • +8 more
    Dec 20, 2021

    COVID-19, Severe Acute Respiratory Syndrome (SARS), Coronavirus Infections Trial in Royal Oak (COVID-19 convalescent plasma)

    Terminated
    Has Results
    • COVID-19
    • +2 more
    • COVID-19 convalescent plasma
    • Royal Oak, Michigan
      William Beaumont Hospital
    Mar 7, 2022

    Nasopharyngeal Carcinoma Trial in Guangzhou (mobile platform or not mobile platform)

    Recruiting
    • Nasopharyngeal Carcinoma
    • mobile platform or not mobile platform
    • Guangzhou, Guangdong, China
      Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
    Apr 17, 2023

    Autologous Haematopoietic Stem Cell Transplant Trial in China (plerixafor + G-CSF)

    Recruiting
    • Autologous Haematopoietic Stem Cell Transplant
    • plerixafor + G-CSF
    • China, China
      Investigational Sites
    May 4, 2022

    Advanced Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial in Seattle

    Terminated
    • Advanced Hepatocellular Carcinoma
    • +2 more
    • Cabozantinib S-malate
    • Pembrolizumab
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 12, 2022

    Non Small Cell Lung Cancer (NSCLC) Trial in India (Osimertinib)

    Completed
    Has Results
    • Non Small Cell Lung Cancer (NSCLC)
    • Hyderabad, India
    • +6 more
    May 10, 2021

    Peritoneal Dialysis Trial (Administration of an IV glucose-injection)

    Withdrawn
    • Peritoneal Dialysis
    • Administration of an IV glucose-injection
    • (no location specified)
    Jul 5, 2021

    Ischemic Stroke Trial in Beijing (improvement of quality of stroke care)

    Completed
    • Ischemic Stroke
    • improvement of quality of stroke care
    • Beijing, Beijing, China
      Beijing Tiantan Hospital, Capital Medical University
    Oct 26, 2021